Clinical Working Groups
For each patient group/disease area approved for inclusion in the national infrastructure for whole genome sequencing, a national specialist network is established. The national specialist networks are to provide healthcare expertise and advice on the respective patient group to the National Genome Center (DNGC) for the purpose of national implementation of whole genome sequencing.
The purpose of the national specialist networks is primarily to contribute to achieving the clinical potential for patient access to whole genome sequencing within the specific disease area, within the frameworks established during the decision-making process regarding inclusion. This includes ensuring that patients across the country have equal access to whole genome sequencing through coordinated and uniform implementation and clinical use.
Additionally, the national specialist networks are to advise on the follow-up regarding the clinical effectiveness of the intervention.
The Specialist Network has the following overall tasks
- Clinical delimitation of the patient group with suggestions for clinical application and number of whole genome sequencing (WGS)
- Mapping of the current national set-up for assessment and treatment of the patient group
- Follow-up on the implementation of whole genome sequencing for the patient group – assessment of clinical effectiveness